Skip to main content

Featured

Territorial Disputes Dominate Geneva Peace Talks

US President Donald Trump's son-in-law Jared Kushner, US Special Envoy Steve Witkoff, US Secretary of State Marco Rubio, US Army Secretary Daniel Driscoll sit before closed-door talks with Head of the Office of the President of Ukraine Andriy Yermak  (not pictured) on ending Russia's war in Ukraine, at the US Mission in Geneva, Switzerland. Negotiators from Russia and Ukraine convened in Geneva for a new round of U.S.-mediated peace talks, with territorial disputes emerging as the central point of contention. The discussions, held over two days, come amid heightened pressure from U.S. President Donald Trump, who has urged Kyiv to “come to the table fast” in pursuit of a settlement.  Both sides remain deeply divided over land claims, which have become the primary obstacle to progress. The Kremlin has signaled that territorial issues will dominate the agenda, while Ukrainian President Volodymyr Zelenskyy has voiced concerns that Kyiv is facing disproportionate p...

article

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Comments